MMP Stock Recent News
MMP LATEST HEADLINES
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, announced the presentation of additional human imaging data that validate the potential of MT1-MMP, a tumor antigen overexpressed in many cancers, as a novel target for cancer treatment and demonstrate the positive properties of Bicycle® Radioconjugates (BRC®).
ONEOK announced a merger with Magellan Midstream Partners, one of the largest deals in the energy sector, which will significantly increase OKE's EBITDA. The Company has consistently grown its EPS by 14% annually through acquisitions, and its yield above 5% makes it an enticing investment. Despite concerns about debt levels and achieving expected synergies from the merger, OKE's resilience and strategic ambitions make it a buy.
With Wall Street ending a tumultuous week amid a hawkish Fed outlook, investors should invest in safe stocks like Magellan Midstream Partners (MMP), Trinity Capital (TRIN), Runway Growth Finance (RWAY) & Postal Realty Trust (PSTL).
Magellan Midstream holders have approved the acquisition deal by ONEOK, despite concerns over tax consequences. The deal will create a more diversified company, with ONEOK bringing natural gas and natural gas liquids to the table. The combined company is expected to generate about $6.1 billion in adjusted EBITDA in 2024, valuing it at roughly 10x 2024 EBITDA.
The proposed transaction involves the acquisition of all outstanding units of Magellan Midstream (MMP) by ONEOK through a mixture of cash and stock.
The $19 billion transaction was was approved at a unit holder meeting Thursday, despite some investor opposition to the deal.
Magellan Midstream Partners' unitholders on Thursday voted in favour of the U.S. pipeline operator's planned sale to larger peer ONEOK Inc for $18.8 billion.
Does Magellan Midstream Partners (MMP) have what it takes to be a top stock pick for momentum investors? Let's find out.
ALPS Advisors, which runs a big ETF, backs Magellan's deal with Oneok but many retail investors oppose it. The vote is Thursday.
Magellan Midstream Partners has pressed its case for the $19 billion deal, citing strategic benefit and downplaying tax issues ahead of next week's vote.